The presence of anti‐ganglioside antibodies (IgM or IgG) was found in patients with an axonal (4/6, 67%) as well as in patients with a demyelinating electrophysiological subtype of GBS (14/28, 50%). This evidence concerns the gene CD40LG and Guillain-Barre syndrome.